Lack of In Vitro and In Vivo Recognition of Francisella tularensis Subspecies Lipopolysaccharide by Toll-Like Receptors
暂无分享,去创建一个
Samuel I. Miller | D. Goodlett | A. Sjöstedt | S. Shaffer | M. Forsman | Christopher B Wilson | A. Hajjar | R. Ernst | S. Skerrett | M. Byström | M. Pelletier | H. Edebro | M. D. Harvey
[1] S. Michalek,et al. Immunologic Consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the Innate Immune Response in Infection and Immunity1 , 2006, The Journal of Immunology.
[2] M. Apicella,et al. Basis for the Failure of Francisella tularensis Lipopolysaccharide To Prime Human Polymorphonuclear Leukocytes , 2006, Infection and Immunity.
[3] C. García-Rodríguez,et al. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS. , 2006, International immunology.
[4] M. Muroi,et al. Structural Regions of MD-2 That Determine the Agonist-Antagonist Activity of Lipid IVa* , 2006, Journal of Biological Chemistry.
[5] A. Sjöstedt,et al. Virulence comparison in mice of distinct isolates of type A Francisella tularensis. , 2006, Microbial pathogenesis.
[6] C. Coban,et al. Manifold Mechanisms of Toll-Like Receptor-Ligand Recognition , 2005, Journal of Clinical Immunology.
[7] Richard W Titball,et al. Vaccination strategies for Francisella tularensis. , 2005, Advanced drug delivery reviews.
[8] M. Forsman,et al. Evolution of Subspecies of Francisella tularensis , 2005, Journal of bacteriology.
[9] A. Sjöstedt,et al. Worldwide Genetic Relationships among Francisella tularensis Isolates Determined by Multiple-Locus Variable-Number Tandem Repeat Analysis , 2004, Journal of bacteriology.
[10] B. Gibson,et al. Novel Modification of Lipid A of Francisella tularensis , 2004, Infection and Immunity.
[11] Samuel I. Miller,et al. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[12] D. Persing,et al. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents , 2004, Expert opinion on biological therapy.
[13] Makiko Kobayashi,et al. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. , 2004, International immunology.
[14] A. Wiese,et al. Endotoxins: relationships between structure, function, and activity. , 2004, Current topics in medicinal chemistry.
[15] Samuel I. Miller,et al. Variation in lipid A structure in the pathogenic yersiniae , 2004, Molecular microbiology.
[16] H. D. Liggitt,et al. Cutting Edge: Myeloid Differentiation Factor 88 Is Essential for Pulmonary Host Defense against Pseudomonas aeruginosa but Not Staphylococcus aureus1 , 2004, The Journal of Immunology.
[17] M. Trent,et al. Biosynthesis, transport, and modification of lipid A. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[18] Tara L. Kieffer,et al. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. , 2003, Microbes and infection.
[19] R. Titball,et al. Will the enigma of Francisella tularensis virulence soon be solved? , 2003, Trends in microbiology.
[20] A. Sjöstedt,et al. Discrimination of Human Pathogenic Subspecies of Francisella tularensis by Using Restriction Fragment Length Polymorphism , 2003, Journal of Clinical Microbiology.
[21] E. Vinogradov,et al. Structural analysis of Francisella tularensis lipopolysaccharide. , 2002, European journal of biochemistry.
[22] R. Coler,et al. Taking toll: lipid A mimetics as adjuvants and immunomodulators. , 2002, Trends in microbiology.
[23] Samuel I. Miller,et al. Human Toll-like receptor 4 recognizes host-specific LPS modifications , 2002, Nature Immunology.
[24] A. Aderem,et al. Cutting Edge: Functional Interactions Between Toll-Like Receptor (TLR) 2 and TLR1 or TLR6 in Response to Phenol-Soluble Modulin1 , 2001, The Journal of Immunology.
[25] S. Vogel,et al. Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.
[26] D. Schwartz,et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.
[27] K. Elkins,et al. Purified Lipopolysaccharide from Francisella tularensis Live Vaccine Strain (LVS) Induces Protective Immunity against LVS Infection That Requires B Cells and Gamma Interferon , 2000, Infection and Immunity.
[28] J. Baldridge,et al. Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines. , 1999, Methods.
[29] E. Chi,et al. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[30] Samuel I. Miller,et al. How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. , 1999, The Journal of infectious diseases.
[31] Samuel I. Miller,et al. Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides , 1998, Cell.
[32] K. Watanabe,et al. Chemical and biological properties of lipopolysaccharide from Selenomonas sputigena ATCC 33150. , 1997, Oral microbiology and immunology.
[33] R. Darveau,et al. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. , 1996, The Journal of clinical investigation.
[34] R. Page,et al. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion , 1995, Infection and immunity.
[35] D. Golenbock,et al. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. , 1991, The Journal of biological chemistry.
[36] M. Caroff,et al. Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the "isolated lipid A" fragment of the Bordetella pertussis endotoxin. , 1988, Carbohydrate research.
[37] W. Fischer,et al. Improved preparation of lipoteichoic acids. , 1983, European journal of biochemistry.
[38] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.
[39] Samuel I. Miller,et al. LPS, TLR4 and infectious disease diversity , 2005, Nature Reviews Microbiology.
[40] C. Whitfield,et al. Lipopolysaccharide endotoxins. , 2002, Annual review of biochemistry.
[41] E. Rietschel,et al. Bacterial lipopolysaccharides and innate immunity. , 2001, Journal of endotoxin research.
[42] M. Hackett,et al. Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria. , 2000, The Analyst.
[43] J. T. Ulrich,et al. Monophosphoryl Lipid A as an Adjuvant , 1995 .
[44] R. Page,et al. The ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and neutrophil adhesion. , 1995, Progress in clinical and biological research.
[45] J. T. Ulrich,et al. Monophosphoryl lipid A as an adjuvant. Past experiences and new directions. , 1995, Pharmaceutical biotechnology.
[46] A. Sjöstedt,et al. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. , 1994, International journal of systematic bacteriology.
[47] O. Westphal. Bacterial lipopolysaccharides : extraction with phenol-water and further applications of the procedure , 1965 .